InfuSystem Holdings Files 8-K for Regulation FD Disclosure

Ticker: INFU · Form: 8-K · Filed: May 1, 2025 · CIK: 1337013

Infusystem Holdings, INC 8-K Filing Summary
FieldDetail
CompanyInfusystem Holdings, INC (INFU)
Form Type8-K
Filed DateMay 1, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: regulation-fd, disclosure

TL;DR

InfuSystem Holdings filed an 8-K for a Reg FD disclosure. No major news, just compliance.

AI Summary

InfuSystem Holdings, Inc. filed an 8-K on May 1, 2025, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or material events beyond the disclosure itself. The company, formerly known as Healthcare Acquisition Partners Corp. and HAPC, Inc., is incorporated in Delaware and headquartered in Rochester Hills, Michigan.

Why It Matters

This filing indicates InfuSystem Holdings is making a public disclosure under Regulation FD, which ensures fair disclosure of material information to all investors.

Risk Assessment

Risk Level: low — The filing is a standard regulatory disclosure without any new material financial information or significant corporate events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report a Regulation FD Disclosure.

What is the exact date of the earliest event reported in this filing?

The date of the earliest event reported is May 1, 2025.

What is the company's state of incorporation?

The company is incorporated in Delaware.

What is the principal executive office address of InfuSystem Holdings, Inc.?

The principal executive office is located at 3851 West Hamlin Road, Rochester Hills, Michigan 48309.

What were some of the former names of InfuSystem Holdings, Inc.?

Former names include HAPC, Inc. and Healthcare Acquisition Partners Corp.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 1, 2025 regarding InfuSystem Holdings, Inc (INFU).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing